Full Text View
Tabular View
No Study Results Posted
Related Studies
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
This study has been completed.
Study NCT00147225   Information provided by M.D. Anderson Cancer Center

First Received on September 6, 2005.   Last Updated on March 13, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumors
Advanced Cancer
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
AMG 531
Carboplatin
Adriamycin
Ifosfamide
Additional drug interventions recognized in this trial
Doxorubicin
Isophosphamide mustard
More general drug interventions related to this trial
Alkylating Agents
Antibiotics, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services